Granite Point Capital Management, L.P. - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 85 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Granite Point Capital Management, L.P. ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$174,000
-48.8%
46,000
-16.1%
0.03%
+17.4%
Q2 2019$340,000
-12.8%
54,8220.0%0.02%
-39.5%
Q1 2019$390,000
-16.7%
54,8220.0%0.04%
-60.0%
Q4 2018$468,000
-88.0%
54,822
-71.8%
0.10%
-63.3%
Q3 2018$3,898,000
-25.3%
194,715
-3.7%
0.26%
-44.7%
Q2 2018$5,221,000
-10.1%
202,115
-16.8%
0.47%
-16.6%
Q1 2018$5,806,000
-36.7%
242,915
-10.2%
0.56%
-37.5%
Q4 2017$9,168,000
+29.8%
270,515
-18.9%
0.90%
-39.7%
Q3 2017$7,061,000
+53.2%
333,515
+26.6%
1.49%
+30.7%
Q2 2017$4,609,000
+11.8%
263,515
+11.9%
1.14%
-7.6%
Q1 2017$4,122,000
-4.7%
235,515
-8.0%
1.23%
-64.3%
Q4 2016$4,327,000
+17.5%
256,031
+14.1%
3.45%
+140.1%
Q3 2016$3,681,000
+8.4%
224,3310.0%1.44%
-1.4%
Q2 2016$3,396,000
+19.2%
224,331
+122.9%
1.46%
+241.2%
Q4 2015$2,850,000
+206.1%
100,631
+80.9%
0.43%
-33.1%
Q3 2015$931,000
-42.6%
55,631
-10.0%
0.64%
+35.2%
Q2 2015$1,621,000
+50.7%
61,8130.0%0.47%
+19.8%
Q1 2015$1,076,000
+0.7%
61,8130.0%0.39%
-21.4%
Q4 2014$1,068,000
+3.1%
61,8130.0%0.50%
-2.9%
Q3 2014$1,036,00061,8130.52%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 657,467$2,709,0002.82%
Healthcare Value Capital, LLC 100,000$412,0001.36%
Opaleye Management Inc. 1,487,800$6,130,0001.20%
Worth Venture Partners, LLC 225,106$927,0000.76%
ARMISTICE CAPITAL, LLC 2,742,000$11,297,0000.41%
DELTEC ASSET MANAGEMENT LLC 355,845$1,466,0000.26%
ESSEX INVESTMENT MANAGEMENT CO LLC 329,437$1,357,0000.19%
Mosaic Family Wealth, LLC 92,357$381,0000.14%
EMERALD ADVISERS, LLC 642,226$2,646,0000.11%
DCF Advisers, LLC 31,236$129,0000.07%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders